Oxford Asset Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$296K Buy
+3,790
New +$306K 0.15% 213
2025
Q2
– Sell
-3,191
Closed -$287K – 662
2025
Q1
$287K Sell
3,191
-4,251
-57% -$380K 0.13% 263
2024
Q4
$594K Buy
7,442
+3,068
+70% +$266K 0.26% 127
2024
Q3
$394K Buy
+4,374
New +$368K 0.33% 104
2024
Q1
– Sell
-2,542
Closed -$209K – 320
2023
Q4
$209K Buy
+2,542
New +$194K 0.31% 136
2020
Q1
– Sell
-28,941
Closed -$3.28M – 835
2019
Q4
$3.28M Sell
28,941
-114,359
-80% -$12.5M 0.09% 228
2019
Q3
$15.6M Buy
143,300
+140,647
+5,301% +$14.7M 0.37% 28
2019
Q2
$258K Sell
2,653
-130,788
-98% -$11.9M 0.01% 1490
2019
Q1
$12.2M Buy
133,441
+19,942
+18% +$1.78M 0.27% 53
2018
Q4
$10.3M Buy
113,499
+70,403
+163% +$6.58M 0.27% 69
2018
Q3
$4.24M Buy
+43,096
New +$3.98M 0.09% 277

Other funds holding MDT

Oxford Asset Management's MDT Position: Q2 2026 in Review

Oxford Asset Management opened a new position in Medtronic (MDT) in Q2 2026: 3,790 shares worth $296K. The stake represents 0.15% of the portfolio and ranks #213 among its holdings. This is a return to the name: Oxford Asset Management previously reported a position in MDT as recently as Q1 2025.

Oxford Asset Management first reported a position in MDT in Q3 2018 and has held it in 11 quarters since. The position peaked at $15.6M in Q3 2019. 2,146 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Oxford Asset Management held 3,790 shares of Medtronic worth $296K as of Q2 2026.
  • Medtronic was a new Oxford Asset Management position in Q2 2026.
  • Medtronic made up 0.15% of Oxford Asset Management's portfolio in Q2 2026, its #213 holding.
  • Oxford Asset Management first reported a position in Medtronic in Q3 2018 and has held it in 11 quarters since.
  • Oxford Asset Management's Medtronic position peaked at $15.6M in Q3 2019.
  • 2,146 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Oxford Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.